title: [Screening methods in genetic diagnosis of hereditary protein C deficiency].
abstract: Genomic analysis and detailed blood coagulation examinations of 22 family members of 18 families with repeatedly low protein C activity have been performed. Blood coagulation examinations: INR, fibrinogen, plasminogen, alpha-2-antiplasmin, lupus anticoagulant, APC resistance test, protein C activity and antigen, protein S activity and antithrombin activity. Genetic examinations: the presence of FII G20210A alle and FV:Q506 Leiden mutation were examined and for the mutation screening in the protein C gene combination of polymerase chain reaction (PCR) with denaturing gradient gelelectrophoresis (DGGE) or with single-strand conformation polymorphism (SSCP) analysis has been performed. The amplified DNA fragments with aberrant migration during DGGE and SSCP analysis were sequenced. Nine family members of seven families were identified carrying mutations in the protein C gene: one nonsense mutation in exon VII (Arg 157-Stop), two types of missense mutations in four patients in exon IXA (230 Arg-Lys, 254 Thr-Ile, the latter is a new mutation, Protein C Pécs), one missense mutation in two patients in exon IXB (325 Val-Ala), one missense mutation in exon IXC (359 Asp-Asn) and a rare frameshift deletion in exon IXC (364 Met-Trp, 378 Stop). Nine families were evaluated carrying no mutation in their protein C gene, but other genetic or blood coagulation disturbances have been identified, eight of them had borderline decrease in their protein C activity (60-70%). The presence of FV:Q506 mutation could be diagnosed in eight families (in 3 cases homozygous, in 5 cases heterozygous form), among them combination of the defects could be proved in three of the eight families: FV:Q506 Leiden mutation with antiphospholipoid antibodies in 2 families and the presence of Leiden mutation with prothrombin gene mutation in 1 family. Protein S deficiency in combination with prothrombin gene mutation has been identified in 1 family. There were 2 families where no genetic or blood coagulation alterations could be detected in the background of the repeatedly low protein C activity. Large deletions or insertions which are not detectable by our screening methods could not be excluded in these families and therefore sequencing of the total protein C gene had been performed with negative results. According to the literature and our experience the screening methods that were administered in this study are suitable for the detection of mutations in the protein C gene.
authors.affiliation: Pécsi Orvostudományi Egyetem, I. sz. Belgyógyászati Klinika.
authors.forename: M
authors.initials: M
authors.lastname: Dávid
authors.forename: H
authors.initials: H
authors.lastname: Losonczy
authors.forename: A
authors.initials: A
authors.lastname: Nagy
authors.forename: G
authors.initials: G
authors.lastname: Kutscher
authors.forename: M
authors.initials: M
authors.lastname: Meyer
mesh_terms: D000293:Adolescent; D000328:Adult; D001797:Blood Protein Electrophoresis / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D020151:Protein C Deficiency / Q000175:diagnosis / Q000235:genetics*; D019851:Thrombophilia / Q000175:diagnosis / Q000235:genetics*